Synthetic strigolactone analogues reveal anti-cancer activities on hepatocellular carcinoma cells.

[1]  S. Friedman,et al.  Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis. , 2017, Gastroenterology.

[2]  A. Abrantes,et al.  Targeting Hepatocellular Carcinoma: What did we Discover so Far? , 2016, Oncology reviews.

[3]  Ching-Lung Lai,et al.  Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region , 2016, Gut and liver.

[4]  R. Yarden,et al.  Strigolactone analogs act as new anti-cancer agents in inhibition of breast cancer in xenograft model , 2015, Cancer biology & therapy.

[5]  S. Baylin,et al.  Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. , 2014, Molecular cell.

[6]  Matthias Dobbelstein,et al.  Targeting tumour-supportive cellular machineries in anticancer drug development , 2014, Nature Reviews Drug Discovery.

[7]  Bipul R. Acharya,et al.  Thymoquinone inhibits microtubule polymerization by tubulin binding and causes mitotic arrest following apoptosis in A549 cells. , 2014, Biochimie.

[8]  A. Tsatsakis,et al.  Assessment of polyphenolic content, antioxidant activity, protection against ROS-induced DNA damage and anticancer activity of Vitis vinifera stem extracts. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[9]  S. Bhushan,et al.  The anticancer potential of flavonoids isolated from the stem bark of Erythrina suberosa through induction of apoptosis and inhibition of STAT signaling pathway in human leukemia HL-60 cells. , 2013, Chemico-biological interactions.

[10]  T. Sharif,et al.  Anti-neoplastic agent thymoquinone induces degradation of α and β tubulin proteins in human cancer cells without affecting their level in normal human fibroblasts , 2012, Investigational New Drugs.

[11]  Y. Kapulnik,et al.  Strigolactones: a novel class of phytohormones that inhibit the growth and survival of breast cancer cells and breast cancer stem-like enriched mammosphere cells , 2012, Breast Cancer Research and Treatment.

[12]  R. Lencioni,et al.  The etiology of hepatocellular carcinoma and consequences for treatment. , 2010, The oncologist.

[13]  T. Sharif,et al.  Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1. , 2010, Biochemical pharmacology.

[14]  David J Newman,et al.  Advanced preclinical and clinical trials of natural products and related compounds from marine sources. , 2004, Current medicinal chemistry.

[15]  Jianbo Xiao,et al.  Characterization of flavonoids from Dryopteris erythrosora and evaluation of their antioxidant, anticancer and acetylcholinesterase inhibition activities. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.